Dairy Trans Fats Pose No Heart or Diabetes Risk, Major 22-Study Review Finds
A large review of 22 studies finds natural trans fats in milk, butter, and cheese don't raise heart disease or type 2 diabetes risk.
Summary
A major review analyzing 22 studies — including 10 controlled dietary trials and 12 long-term cohort studies — found that the naturally occurring trans fats in dairy foods such as milk, butter, yogurt, and cheese do not increase the risk of heart disease or type 2 diabetes. Unlike industrial trans fats from partially hydrogenated oils, which are strongly linked to cardiovascular harm, dairy trans fats showed no meaningful negative effects on blood lipid levels in controlled trials. Long-term cohort studies also found no association between higher blood levels of dairy trans fats and heart disease, stroke, cardiovascular death, or type 2 diabetes. The findings, published in Nutrition Research, suggest consumers and clinicians should distinguish between the two very different categories of trans fats when making dietary decisions.
Detailed Summary
Trans fats have long carried a blanket reputation for harming heart health, but a sweeping new review suggests that reputation unfairly tars dairy foods along with industrial processed products. Researchers at the University of Reading analyzed evidence from 22 studies involving thousands of participants across Europe, North America, and Canada to determine whether naturally occurring dairy trans fats behave the same way in the body as their industrially manufactured counterparts.
The review drew on two distinct lines of evidence. Ten controlled dietary trials had participants consume dairy foods enriched with natural trans fats — at doses ranging from 1.3 to 13.2 grams per day — and compared their blood lipid profiles against those eating regular dairy. Across all ten trials, no meaningful differences emerged in the blood lipid biomarkers used to gauge cardiovascular risk.
Twelve long-term cohort studies, some spanning more than two decades, provided the second pillar of evidence. Researchers measured dairy trans fat levels directly in participants' blood and tracked subsequent health outcomes. Higher circulating levels of dairy trans fats were not associated with elevated rates of heart disease, stroke, cardiovascular death, or type 2 diabetes — outcomes that are closely linked to industrial trans fat consumption.
The biological distinction matters because dairy trans fats — primarily vaccenic acid and conjugated linoleic acid — are structurally different from the trans fats generated during partial hydrogenation of vegetable oils. These differences appear to translate into meaningfully different metabolic effects, though the precise mechanisms remain under investigation.
For health-conscious adults, the practical implication is straightforward: whole dairy foods consumed as part of a balanced diet should not be avoided on the grounds of trans fat content. Clinicians and policymakers may also need to revisit labeling frameworks that lump all trans fats together, as this conflation may be driving unnecessary avoidance of nutritionally valuable foods.
Key Findings
- 10 controlled trials found no meaningful change in blood lipids when participants consumed elevated natural dairy trans fats.
- 12 long-term cohort studies found no link between dairy trans fat blood levels and heart disease, stroke, or cardiovascular death.
- Higher dairy trans fat levels were not associated with increased type 2 diabetes risk across long-term studies.
- Naturally occurring dairy trans fats are structurally distinct from industrial trans fats and appear metabolically safer.
- Current food labeling policies that group all trans fats together may mislead consumers about dairy food safety.
Methodology
This is a news report summarizing a systematic review published in the peer-reviewed journal Nutrition Research, led by researchers at the University of Reading. The evidence base combines 10 controlled dietary trials and 12 prospective cohort studies, representing a robust and diverse body of evidence. As a review article, conclusions depend on the quality and consistency of the underlying primary studies.
Study Limitations
The review is summarized via a news release; full methodology, heterogeneity analysis, and quality scoring of included studies should be verified in the primary Nutrition Research publication. Controlled trials used a wide dose range (1.3–13.2 g/day), and real-world dairy consumption patterns may differ. Cohort studies rely on biomarker proxies for intake, and residual confounding from overall diet quality cannot be fully excluded.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: